{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:08:14Z","timestamp":1789650494379,"version":"4.0.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1695,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1002\/hep.24098","type":"journal-article","created":{"date-parts":[[2010,12,6]],"date-time":"2010-12-06T12:39:18Z","timestamp":1291639158000},"page":"596-603","source":"Crossref","is-referenced-by-count":68,"title":["Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection"],"prefix":"10.1097","volume":"53","author":[{"given":"Marie-Luise","family":"Berres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Schmeding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Eurich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Bahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf P.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann E.","family":"Wasmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2011,1,10]]},"reference":[{"key":"10.1002\/hep.24098-BIB1|cit1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/jlts.2003.50268","article-title":"Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C","volume":"9","author":"Wiesner","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1002\/hep.24098-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1600-6143.2009.02702.x","article-title":"A practical guide to the management of HCV infection following liver transplantation","volume":"9","author":"Watt","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1002\/hep.24098-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMct061675","article-title":"Peginterferon and ribavirin for chronic hepatitis C","volume":"355","author":"Hoofnagle","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1002\/hep.24098-BIB4|cit4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C infection after liver transplantation","volume":"334","author":"Gane","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/hep.24098-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/lt.21954","article-title":"Natural history of post-liver transplantation hepatitis C: a review of factors that may influence its course","volume":"15","author":"Gallegos-Orozco","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1002\/hep.24098-BIB6|cit6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.tp.0000250575.92788.aa","article-title":"Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (interferon-ribavirin therapy)","volume":"83","author":"Bahra","year":"2007","journal-title":"Transplantation"},{"key":"10.1002\/hep.24098-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1053\/j.gastro.2008.02.069","article-title":"Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors","volume":"134","author":"Missiha","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.24098-BIB8|cit8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gut.51.2.248","article-title":"Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C","volume":"51","author":"Wali","year":"2002","journal-title":"Gut"},{"key":"10.1002\/hep.24098-BIB9|cit9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/lt.20648","article-title":"Influence of donor\/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation","volume":"12","author":"Langrehr","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1002\/hep.24098-BIB10|cit10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.TP.0000101738.27552.9D","article-title":"Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up","volume":"77","author":"Neumann","year":"2004","journal-title":"Transplantation"},{"key":"10.1002\/hep.24098-BIB11|cit11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1399-3062.2009.00370.x","article-title":"Serum levels of fibrosis biomarkers measured early after liver transplantation are associated with severe hepatitis C virus recurrence","volume":"11","author":"Micheloud","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1002\/hep.24098-BIB12|cit12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0030-1255351","article-title":"Chemokines in liver inflammation and fibrosis","volume":"30","author":"Wasmuth","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1002\/hep.24098-BIB13|cit13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-0028-1109933","article-title":"Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines [in German]","volume":"48","author":"Wasmuth","year":"2010","journal-title":"Z Gastroenterol"},{"key":"10.1002\/hep.24098-BIB14|cit14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/17474124.2.2.233","article-title":"Chemokine-directed immune cell infiltration in acute and chronic liver disease","volume":"2","author":"Karlmark","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1002\/hep.24098-BIB15|cit15","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.4049\/jimmunol.163.11.6236","article-title":"Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver","volume":"163","author":"Shields","year":"1999","journal-title":"J Immunol"},{"key":"10.1002\/hep.24098-BIB16|cit16","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0002-9440(10)62060-3","article-title":"CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow","volume":"167","author":"Curbishley","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1002\/hep.24098-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20021897","article-title":"An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4","volume":"197","author":"Lasagni","year":"2003","journal-title":"J Exp Med"},{"key":"10.1002\/hep.24098-BIB18|cit18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.gastro.2009.03.053","article-title":"Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans","volume":"137","author":"Wasmuth","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.24098-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/hep.23435","article-title":"The CXC chemokine ligand 4 (CXCL4) is a platelet-derived mediator of experimental liver fibrosis","volume":"51","author":"Zaldivar","year":"2010","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.24098-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1086\/646614","article-title":"Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection","volume":"200","author":"Zeremski","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1002\/hep.24098-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/hep.22500","article-title":"Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C","volume":"48","author":"Zeremski","year":"2008","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.24098-BIB22|cit22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/507307","article-title":"Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection","volume":"194","author":"Romero","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1002\/hep.24098-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/hep.23509","article-title":"Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C","volume":"51","author":"Askarieh","year":"2010","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.24098-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/hep.21407","article-title":"IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection","volume":"44","author":"Lagging","year":"2006","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.24098-BIB25|cit25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.22950","article-title":"Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis","volume":"50","author":"Karlmark","year":"2009","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.24098-BIB26|cit26","doi-asserted-by":"crossref","unstructured":"Seki E de Minicis S Inokuchi S Taura K Miyai K van Rooijen N CCR2 promotes hepatic fibrosis in mice 2009 50 185 197","DOI":"10.1002\/hep.22952"},{"key":"10.1002\/hep.24098-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.24098-BIB28|cit28","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jhep.2004.06.029","article-title":"Fibrosis progression after liver transplantation in patients with recurrent hepatitis C","volume":"41","author":"Neumann","year":"2004","journal-title":"J Hepatol"},{"key":"10.1002\/hep.24098-BIB29|cit29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2893.2008.01019.x","article-title":"Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies","volume":"15","author":"Xirouchakis","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1002\/hep.24098-BIB30|cit30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.23340","article-title":"Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis","volume":"51","author":"Bruno","year":"2010","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.24098-BIB31|cit31","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.3748\/wjg.14.7149","article-title":"Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection","volume":"14","author":"Larrubia","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1002\/hep.24098-BIB32|cit32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/hep.22763","article-title":"Chemokines in the immunopathogenesis of hepatitis C infection","volume":"49","author":"Heydtmann","year":"2009","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.24098-BIB33|cit33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/hep.21561","article-title":"Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis","volume":"45","author":"Pockros","year":"2007","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.24098-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/00007890-200112270-00016","article-title":"Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants","volume":"72","author":"Goddard","year":"2001","journal-title":"Transplantation"},{"key":"10.1002\/hep.24098-BIB35|cit35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1189\/jlb.0303093","article-title":"Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation","volume":"74","author":"Harvey","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1002\/hep.24098-BIB36|cit36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2008.10.020","article-title":"Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver","volume":"136","author":"Holt","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.24098-BIB37|cit37","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cld.2008.07.002","article-title":"Immune interactions in hepatic fibrosis","volume":"12","author":"Holt","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1002\/hep.24098-BIB38|cit38","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1074\/jbc.M010303200","article-title":"Signal transduction by the chemokine receptor CXCR3: activation of Ras\/ERK, Src, and phosphatidylinositol 3-kinase\/Akt controls cell migration and proliferation in human vascular pericytes","volume":"276","author":"Bonacchi","year":"2001","journal-title":"J Biol Chem"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.24098","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1002\/hep.24098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:27:13Z","timestamp":1789648033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1002\/hep.24098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,10]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.24098","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,10]]}}}